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Introduction
Glycohemoglobin (GHb), measured as HbA1c, is an
invaluable tool for monitoring long-term glycemic con-
trol, and as such is a key issue in diabetes care. HbA1c
is the result of irreversible nonenzymatic glycation at
1 or both N-terminal valines of the Hb β chain.1 This
irreversible nonenzymatic reaction between glucose
and HbA, the main type of Hb in normal adults, occurs
during the life span of the erythrocyte. The total
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of patients with Hb variants.
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Hemoglobin variants and HbA1c
amount depends on the average glucose concentra-
tions within 2–3 months prior to the measurement.2
Although several methods based on different
principles (high-performance liquid chromatography
[HPLC], immunoagglutination, boronate-affinity as-
says, and electrophoresis) have been developed,3,4 the
designated Diabetes Control and Complications Trial
comparison method utilized an ion-exchange HPLC
(Diamat; Bio-Rad, Richmond, CA, USA).5 Therefore,
the majority of HbA1c measurements are still per-
formed by ion-exchange HPLC.
The structural variants and chemical derivatives 
of Hb may interfere with many methods. Most Hb
variants are a single base pair change in the DNA
code, resulting in an amino acid substitution and struc-
tural alteration.6 Such structural variants may demon-
strate additional peaks in the chromatograms and be
combined with clinically low or high results. However,
not all Hb variants affect HbA1c measurement. In
the population with Hb variants, misleadingly high or
low GHb values have been identified by only certain
methods. Among them, the effect of Hb variants is
thought to be greater when ion-exchange HPLC is
used.7,8
More than 700 characterized Hb variants have
been reported.6 The majority arise from point muta-
tions in the α, β, γ, or δ Hb chains.6 In addition, cer-
tain genetic abnormalities can also cause the switch to
adult hemoglobin synthesis to fail, resulting in a con-
dition known as the presence of high fetal hemoglo-
bin (HbF).9 The widespread measurement of GHb
has identified new variants, many of which produce
no phenotypic abnormalities.6
The common Hb variants occurring in southern
Taiwan are not yet clear. Therefore, this study was
designed to investigate the occurrence of Hb variants
and their influence on the measurement of HbA1c.
Methods
A total of 1,434 samples collected for HbA1c meas-
urement at Kaohsiung Veterans General Hospital in
southern Taiwan in March 2008 were submitted for
Hb variant analysis. The blood samples were collected
in EDTA anticoagulation bottles for HbA1c and Hb
variant analysis. This study was approved by the
Medical Ethics and Human Clinical Trial Committee
of Kaohsiung Veterans General Hospital.
In this study, HbA1c measurement was done using
ion-exchange HPLC (Tosoh HLC-723 G7; Tosoh
Co., Tokyo, Japan) as routine analysis. The Tosoh
HLC-723 G7 is a compact analyzer designed for the
measurement of HbA1c under routine laboratory con-
ditions. The analyzer employed was a fully automated
HPLC system using reagents and conditions specifi-
cally designed to separate and quantify Hb A2 and
HbF in a 7.5-minute run. In addition, ion-exchange
HPLC using a Primus CLC-385 Hb variant analyzer
(Primus Co., Kansas City, MO, USA) served for Hb
variant analysis. Hb variants were identified by ion-
exchange HPLC separation of Hb species using a gra-
dient between 2 mobile phases with differences in salt
concentration and pH. CLC-385 resolution relative
retention time table R3-4000 columns served as refer-
ence for the Hb variants obtained. The patients iden-
tified with Hb variants were recalled for further HbA1c
measurement using CLC 330 boronate-affinity chro-
matography (Primus CLC 330; Primus Co.).
Plasma glucose concentrations were measured by
a hexokinase method using an automatic biochemistry
analyzer (Hitachi 7170; Hitachi Co., Tokyo, Japan).
The values of fasting plasma glucose (FPG) were the
means of all the consecutive values 3 months prior to
or during HbA1c analysis. The relationship between
HbA1c and estimated average glucose (eAG) was de-
scribed by the formula:
eAG (mg/dL) = 28.7 × HbA1c – 46.7
The equation resulted from the A1c-Derived Aver-
age Glucose study,10 which affirmed the existence of a
linear relationship between HbA1c and average blood
glucose levels. The values of eAG minus FPG (eAG-
FPG) were calculated for estimation of the accuracy of
HbA1c measurement in the patients with Hb variants.
Statistical analysis
Values are expressed as mean ± standard deviation.
Comparisons between different groups were made by
Student’s t test, except for sex, which was compared
by 2-sample Kolmogorov-Smirnov test. A value of
p < 0.05 was considered statistically significant.
Results
Among the 1,434 patients, 11 patients were found to
have Hb variants. The incidence of Hb variants was
0.76%. The characteristics of all patients and the patients
with Hb variants are shown in Table 1. The mean age
of all patients was 63.8 years (range, 5–96 years). The
female-to-male ratio was 1:1.4. Mean FPG was
162.8 ± 60.5 mg/dL, HbA1c was 8.28 ± 1.97%, and
eAG was 190.9 ± 56.6 mg/dL. In patients with Hb
variants, mean FPG was 149.5 ± 39.9 mg/dL, HbA1c
was 7.29 ± 2.01%, and eAG was 162.5 ± 57.7 mg/dL.
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Among the 11 patients with Hb variants, Hb J
was identified in 4 patients, Hb G in 2, Hb E in 1, Hb
owari in 3, and high HbF in 1 patient (Table 2).
When compared with standard chromatogram
(Figure 1A), the HPLC chromatograms from Tosoh
HLC-723 G7 showed an additional peak between labile
(L) A1c and stable (S) A1c in 2 patients with Hb J
(Figure 1B). However, the other 2 Hb J patients pre-
sented with normal chromatograms. H-V1 peak existed
in both patients with Hb G (Figure 1C). An additional
peak between SA1c and A0 was seen in the patient
with Hb E (Figure 1D). However, there was no abnor-
mal peak in any of the patients with Hb owari (Figure
1E). In the patient with high HbF, an abnormal peak of
the mixture of HbF and LA1c was noted (Figure 1F).
When the values of eAG-FPG were compared
among the patients with HB variants (Table 2) and the
mean value of the total number of patients (Table 1),
lower levels were found in those with Hb J, E and
high HbF. The results suggest that spuriously decreased
HbA1c levels may have occurred among these patients.
On the other hand, patients with Hb G and owari did
not show lower eAG-FPG levels.
The relationship between HbA1c and FPG values
in the patients with Hb variants and non-Hb variants
were compared on scattergrams (Figure 2). The plots
of Hb J, E and high HbF lay below the regression 
line of non-Hb variants. However, the plots of Hb G
and owari lay beside the regression line of non-Hb
variants.
Ten of the 11 patients with Hb variants were re-
called for HbA1c measurement by boronate-affinity
HPLC (Table 3). Inconsistent Hb values were ob-
served among some, but not all, samples of patients
with Hb variants when compared with the ion-
exchange HPLC. The values were higher or lower.
Discussion
In normal adults, Hb consists of ∼ 97% HbA, 2.5%
HbA2, and 0.5% HbF. Fractionation of HbA by chro-
matography identifies several minor peaks referred to
as HbA1, or fast Hbs, which include the glycated
forms HbA1a, HbA1b, and HbA1c.11 These fast Hbs
form as the result of a 2-step reaction. In the first step,
a reversible reaction forms a Schiff base. This reversible
reaction is followed by an irreversible, nonenzymatic
Amadori rearrangement that produces GHb.11 The
glycation alters the structure of the Hb molecule and
Table 1. Patient characteristics*
All patients (n = 1,434) Patients with Hb variants (n = 11)
Sex (F/M) 590/844 6/5
Age (yr) 63.8 ± 14.6 64.1 ± 10.9
FPG (mg/dL) 162.8 ± 60.5 149.5 ± 39.9
HbA1c (%) 8.28 ± 1.97 7.29 ± 2.01
eAG (mg/dL) 190.9 ± 56.6 162.5 ± 57.7
eAG-FPG (mg/dL) 28.1 ± 46.5 13.09 ± 31.6
*No significant difference for any comparison. Hb = hemoglobin; FPG = fasting plasma glucose; HbA1c = hemoglobin A1c; eAG = estimated average glucose;
eAG-FPG = eAG minus FPG.
Table 2. Results of the 11 patients with hemoglobin variants
Patient Age (yr) Sex FPG (mg/dL) HbA1c (%) eAG (mg/dL) eAG-FPG (mg/dL) Hb variant
1 73 F 117 5.0 97 –20 J
2 64 F 91 4.8 91 0 J
3 74 F 134 6.6 143 9 J
4 67 F 137 6.4 140 3 J
5 72 F 209 10.6 258 49 G
6 74 F 186 10.5 255 69 G
7 61 M 103 5.2 103 0 E
8 71 M 161 7.4 166 5 owari
9 59 M 164 8.7 203 39 owari
10 41 M 134 7.5 169 35 owari
11 49 M 208 7.5 169 –39 High HbF
FPG = fasting plasma glucose; HbA1c = hemoglobin A1c; eAG = estimated average glucose; eAG-FPG = eAG minus FPG; HbF = fetal hemoglobin.
J Chin Med Assoc • July 2009 • Vol 72 • No 7 365
Hemoglobin variants and HbA1c
decreases its net positive charge. Many methods of
testing use 1 or both differences to separate GHb from
nonglycated Hbs.
The N-terminal valine of the β chain provides the
most common site of glycation within the Hb tetramer,
accounting for 80% of HbA1.11 The International Fed-
eration of Clinical Chemistry and Laboratory Medicine
defines HbA1c as Hb that is irreversibly glycated at 1
or both N terminal valines of the β chains. Although all
commercially available methods include HbA1c in
GHb measurements, they vary in their ability to detect
non-A1c GHb.
Depending on the method of determination, the
concentration of HbA1c is approximately 4–6% in
healthy patients without diabetes. However, the pres-
ence of Hb variants may falsely produce low values for
HbA1c or spuriously increased HbA1c values. In addi-
tion, high HbF levels have been reported to interfere
with the results of some HbA1c methods, including
boronate-affinity methods.12 The identification of Hb
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Figure 1. Chromatograms from Tosoh HLC-723 G7. (A) Standard chromatogram. There were several peaks including A1a, A1b, F, labile
(L) A1c, stable (S) A1c, and A0. HbA1c was expressed as the percentage of SA1c among total Hb. (B) Chromatogram of Patient 2 with
Hb J. An additional peak between LA1c and SA1c was noted. (C) Chromatogram of Patient 6 with Hb G. An additional peak (H-V1) follow-
ing A0 was noted. (D) Chromatogram of Patient 7 with Hb E. An additional peak between SA1c and A0 was noted. (E) Chromatogram of
Patient 8 with Hb owari. There was no abnormal peak identified. (F) Chromatogram of Patient 11 with high HbF. An abnormal peak of the
mixture of HbF and LA1c was noted.
variants is, therefore, important to avoid inaccurate
GHb results. In general, an Hb variant can be sus-
pected in patients with HbA1c results > 15%, HbA1c
measurements below the nondiabetic reference range,
or when the HbA1c result varies substantially from
other indices of metabolic control and/or clinical
impression.
There are more than 30 different GHb assay meth-
ods available. The influence of Hb variants on GHb
determination is great when using ion-exchange
HPLC. With ion-exchange HPLC methods, clinically
silent Hb variants may cause additional peaks in chro-
matograms, resulting in a false HbA1c value. Therefore,
if an erroneous result is caused by Hb variants, affinity
chromatography may provide a more accurate mea-
sure of HbA1c.13,14 However, incorrect HbA1c values
resulting from affinity chromatography methods have
also been described.12,15,16 Additionally, the influence
of each Hb variant on HbA1c determinations by affin-
ity chromatography is still not fully investigated. In
this study, inconsistently higher or lower HbA1c values
were observed among patients with Hb variants when
compared with ion-exchange chromatography with
affinity chromatography methods. Therefore, affinity
HPLC methods could not resolve the interference of
Hb variants.
Furthermore, fructosamine can be used as a com-
parison because nonenzymatic glycation of serum
proteins, mainly albumin, is not influenced by Hb vari-
ants. However, fructosamine only reflects an average
of blood glucose levels over a shorter period of 2–3
weeks.
A large-scale survey of hemoglobinopathies was
carried out in China and involved 902,204 people in
28 provinces using electrophoretic techniques; a total
of 2,936 pedigrees with abnormal Hb were found.17
J Chin Med Assoc • July 2009 • Vol 72 • No 7366
C.H. Chu, et al
Table 3. Comparisons of HbA1c values by ion-exchange HPLC (Tosoh HLC-723 G7) and boronate-affinity HPLC method (Primus CLC 330)
Patient Hb variant
HbA1c (%)
Tosoh HLC-723 G7 Primus CLC 330
1 J 5.2 6.2
2 J 3.9 5.9
3 J 7.3 6.9
4 J 6.3 6.9
5 G 9.5 10.6
7 E 6 6.6
8 owari 7.9 7.6
9 owari 6.5 5.7
10 owari 9.7 9.7
11 High HbF 7.7 7.1
Hb = hemoglobin; HbA1c = hemoglobin A1c; HbF = fetal hemoglobin.
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Figure 2. Relationship between HbA1c and fasting plasma glucose (FPG) values in patients with Hb variants and non-Hb variants. 
(A) The plots of Hb J, E and high HbF lay below the regression line of non-Hb variants. (B) The plots of Hb G and owari lay beside the
regression line of non-Hb variants.
The incidence of abnormal Hb was 0.33%, and the
incidence in various regions ranged from 0.04% to
6.06%. In our study, the incidence of Hb variants was
0.76%. Hb J, G, E, owari and high HbF accounted
for the common Hb variants in southern Taiwan.
Abnormal HPLC chromatograms and spuriously de-
creased HbA1c levels might possibly have occurred
among some of the patients with Hb variants.
The values of eAG were converted from HbA1c.
Postprandial hyperglycemia made a large contribu-
tion to overall HbA1c levels. Therefore, the values of
FPG and eAG could be mismatched. In our study, the
deviation of eAG-FPG might be caused by the inter-
ference of Hb variants. Nonetheless, the incompatibil-
ity of FPG and HbA1c could not be excluded.
It is essential that clinical laboratories be aware of
the limitations of their HbA1c assays as well as the
importance of visual inspection of ion-exchange chro-
matograms to detect abnormalities (extraordinary peaks
or non-separation of each peak) caused by Hb variants.
These results also underline the need for additional
investigations of interference caused by Hb variants in
all newly developed HbA1c assays.
In conclusion, though the prevalence of Hb vari-
ants in southern Taiwan is low, the possible presence
of spuriously decreased HbA1c levels or abnormal
HPLC chromatograms by using ion-exchange meth-
ods should be kept in mind. In diabetic patients with
Hb variants, adjustment of medications should depend
on serial changes rather than on 1 single HbA1c
value.
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